Hepatitis D medical therapy: Difference between revisions
Joao Silva (talk | contribs) |
Joao Silva (talk | contribs) |
||
Line 7: | Line 7: | ||
==Medical Therapy== | ==Medical Therapy== | ||
Currently there is no effective [[antiviral]] therapy available for treatment of acute or chronic hepatitis D.<ref>{{cite book | last = Fields | first = Bernard | title = Fields virology | publisher = Wolters Kluwer Health/Lippincott Williams & Wilkins | location = Philadelphia | year = 2013 | isbn = 9781451105636 }}</ref> | |||
The goal of treatment in hepatitis D is the clearance of the [[HDV]] and of the HBV helper virus. The complexity of the treatment resides in the need to address two viruses, and in the simplicity of the [[HDV]], which limits the number of targets for therapeutic agents. | The goal of treatment in hepatitis D is the clearance of the [[HDV]] and of the HBV helper virus. The complexity of the treatment resides in the need to address two viruses, and in the simplicity of the [[HDV]], which limits the number of targets for therapeutic agents. | ||
Revision as of 16:13, 6 August 2014
Hepatitis D |
Diagnosis |
Treatment |
Hepatitis D medical therapy On the Web |
American Roentgen Ray Society Images of Hepatitis D medical therapy |
Risk calculators and risk factors for Hepatitis D medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Varun Kumar, M.B.B.S. [2]; João André Alves Silva, M.D. [3] Jolanta Marszalek, M.D. [4]
Overview
Medical Therapy
Currently there is no effective antiviral therapy available for treatment of acute or chronic hepatitis D.[1] The goal of treatment in hepatitis D is the clearance of the HDV and of the HBV helper virus. The complexity of the treatment resides in the need to address two viruses, and in the simplicity of the HDV, which limits the number of targets for therapeutic agents.
References
- ↑ Fields, Bernard (2013). Fields virology. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins. ISBN 9781451105636.